Nitroimidazole

1 marketed 2 in Phase 3

This page covers all Nitroimidazole drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Anaerobic bacteria and certain protozoa, dihydrofolate reductase (DHFR).

Targets

Anaerobic bacteria and certain protozoa · dihydrofolate reductase (DHFR)

Marketed (1)

Metronidazole 1 g Intravenous · Hospital Universitari Vall d'Hebron Research Institute · Infectious Disease

Phase 3 pipeline (2)

Pretomanid (Pa) · Wuhan Pulmonary Hospital · Infectious Diseases
Pretomanid is a prodrug that is converted into its active form, which inhibits the enzyme dihydrofolate reductase (DHFR) in Mycobacterium tuberculosis.
Standard treatment with benznidazole · Laboratorio Elea Phoenix S.A. · Infectious Diseases
Benznidazole is an antiparasitic drug that works by inhibiting the growth of the parasite Trypanosoma cruzi.